(Reston, Va.) March 29, 2017 - Leidos (NYSE: LDOS), a global science and technology solutions leader, today announced the appointment of Bill Kloes as Vice President, Operations Integration for the Health Group, effective March 29. Kloes will report to Tom Aikens, Leidos Health President, Hospitals & Health Systems. In his role, Kloes will drive Leidos Health new business growth by bringing enterprise products and solution offerings to existing commercial customers. He will also be responsible for driving development and growth of these new and emerging offerings to positively impact patient care, patient safety, and hospital system efficiencies.

Prior to Leidos, Kloes served as VP, Healthcare Professional Services at Nuance Communications, Inc., where he was responsible for defining and executing on a comprehensive professional services and customer success strategy driving growth for the $1B Nuance Healthcare Division. He has also held senior management positions at McKesson Corporation including Vice President, Healthcare Professional services where he oversaw the $200M Managed Services business; Vice President, Professional Services, Health Systems Enterprise Solutions; and Vice President/General Manager of the Enterprise Imaging Group. Kloes holds a Bachelor of Science from Illinois State University.

'Bill has demonstrated expertise at developing, facilitating, and implementing high-tech healthcare strategies that drive business and generate growth,' said Leidos Health President, Hospitals & Health Systems, Tom Aikens. 'We expect Bill to bring an enduring value to our existing commercial customers.'

About Leidos

Leidos is a global science and technology solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $7.04 billion for the fiscal year ended December 30, 2016. For more information, visit www.Leidos.com.
###

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 30, 2016, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

Leidos Holdings Inc. published this content on 29 March 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 29 March 2017 13:14:14 UTC.

Original documenthttp://investors.leidos.com/phoenix.zhtml?c=193857&p=irol-newsArticle&ID=2257254

Public permalinkhttp://www.publicnow.com/view/CBB119BC75E85DD46BB361A0B85E0ECF01288E46